Potential use of pentoxifylline in cancer therapy

Grzegorz Gołuński , Anna Woziwodzka , Jacek Piosik


Background: Pentoxifylline (PTX) is a drug commonly used in the treatment of intermittent claudication. However, numerous research groups report that PTX also may potentially be used in the anticancer therapy following one of the main trends in the nowadays medicine - combined anticancer therapy. Scope of Review: The review concentrates on the reports revealing the potential use of PTX in cancer treatment. Major Conclusion: PTX is described to possess several properties which may be exploited in cancer treatment. The drug reportedly not only has anticancer activity itself, but also increases cancer cells susceptibility to radiation therapy and, additionally, reduces long-term side effects of this therapy. Furthermore, numerous research groups report that PTX may increase the anticancer potential of commonly used anticancer drugs such as cisplatin or doxorubicin as well as reduce side effects of these drugs. Significance: PTX should be considered as a potential drug in the combined anticancer therapy.
Author Grzegorz Gołuński (IFB)
Grzegorz Gołuński,,
- Intercollegiate Faculty of Biotechnology UG
, Anna Woziwodzka (IFB/IB/DMCB)
Anna Woziwodzka,,
- Department of Molecular and Cellular Biology
, Jacek Piosik (IFB/IB/DMCB)
Jacek Piosik,,
- Department of Molecular and Cellular Biology
Journal seriesCurrent Pharmaceutical Biotechnology, ISSN 1389-2010, (A 30 pkt)
Issue year2018
Publication size in sheets0.50
Keywords in Englishradiosensitization, drug interactions, methylxanthines, anticancer drugs, chemotherapy, drug toxicity
ASJC Classification3003 Pharmaceutical Science; 1305 Biotechnology
Languageen angielski
Score (nominal)30
Score sourcejournalList
ScoreMinisterial score = 30.0, 28-01-2020, ArticleFromJournal
Publication indicators WoS Citations = 1.000; Scopus SNIP (Source Normalised Impact per Paper): 2018 = 0.439; WoS Impact Factor: 2018 = 1.516 (2) - 2018=1.743 (5)
Citation count*
Share Share

Get link to the record

* presented citation count is obtained through Internet information analysis and it is close to the number calculated by the Publish or Perish system.
Are you sure?